Bioceres Crop Solutions Corp. (BIOX)
NASDAQ: BIOX · Real-Time Price · USD
6.44
-0.02 (-0.31%)
Nov 21, 2024, 4:00 PM EST - Market closed
Bioceres Crop Solutions Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for BIOX stock have an average target of 13.9, with a low estimate of 9.50 and a high estimate of 21. The average target predicts an increase of 115.84% from the current stock price of 6.44.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BIOX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 → $9.5 | Strong Buy | Maintains | $10 → $9.5 | +47.52% | Nov 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $16 → $13 | Buy | Maintains | $16 → $13 | +101.86% | Oct 21, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $10 | Strong Buy | Maintains | $13 → $10 | +55.28% | Oct 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $17 → $13 | Strong Buy | Maintains | $17 → $13 | +94.10% | Sep 11, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $15 → $13 | Strong Buy | Maintains | $15 → $13 | +101.86% | Sep 11, 2024 |
Financial Forecast
Revenue This Year
508.65M
from 464.83M
Increased by 9.43%
Revenue Next Year
560.32M
from 508.65M
Increased by 10.16%
EPS This Year
0.33
from 0.05
Increased by 538.75%
EPS Next Year
0.65
from 0.33
Increased by 100.00%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 532.0M | 577.5M | 976.6M | ||
| Avg | 508.7M | 560.3M | 948.7M | ||
| Low | 480.2M | 537.2M | 911.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.5% | 13.5% | 74.3% | ||
| Avg | 9.4% | 10.2% | 69.3% | ||
| Low | 3.3% | 5.6% | 62.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.38 | 0.71 | 2.15 | ||
| Avg | 0.33 | 0.65 | 2.09 | ||
| Low | 0.25 | 0.60 | 2.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 639.7% | 118.8% | 229.7% | ||
| Avg | 538.7% | 100.0% | 220.3% | ||
| Low | 379.5% | 83.1% | 207.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.